Olfactory reference syndrome treated with quetiapine: A case

Objective & Hypothesis:Olfactory reference syndrome (ORS) is a rare disorder in which the affected person is excessively preoccupied by the concern that their body emits very unpleasant odors and believes people have negative reactions to this perceived fault.

📊

Key Findings & Data:In literature, several ORS cases, successfully treated by pimozide and risperidone, have been reported, though no report was found about quetiapine-treated ORS.

💡

Conclusion & Impact:Here, we report a case treated with quetiapine involving a man who believed that he emitted the odor of feces.

🔬Design:Research Article

📍Scope:Comprehensive Sample

⚙️Variables:Domain Parameters

Abstract

Olfactory reference syndrome (ORS) is a rare disorder in which the affected person is excessively preoccupied by the concern that their body emits very unpleasant odors and believes people have negative reactions to this perceived fault. In literature, several ORS cases, successfully treated by pimozide and risperidone, have been reported, though no report was found about quetiapine-treated ORS. Here, we report a case treated with quetiapine involving a man who believed that he emitted the odor of feces.

Özet

Olfaktör referans sendromu (ORS) kişinin kendi bedeninin çok kötü bir koku yaydığına ve bu kötü koku yüzünden insanların kendisi hakkında olumsuz fikirler taşıdığına inandığı, bununla ilgili aşırı bir zihinsel meşguliyet içinde olduğu, nadir görülen bir ruhsal bozukluktur. Literatürde pimozid ve risperidon ile tedavi edilmiş ORSli olgular bildirilmektedir. Ancak ketiyapin ile tedavi edilen bir olguya rastlanılmamıştır. Olgumuzda vücudundan gaita kokusu yayıldığı ile ilgili hezeyanı bulunan bir hastanın ketiyapin ile tedavisi sunulmuştur.

🔖

Cite This Article

KORKMAZ, S., NAMLI, M. N., KULOĞLU, M., ATMACA, M., KORKMAZ, H. (2022). Olfactory reference syndrome treated with quetiapine: A case. Klinik Psikofarmakoloji Bülteni, Cilt: 21 - Sayı: 3, 246–248. https://ajindex.com/articles/574164

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (10)

Pryse-Philips W. An olfactory reference syndrome. Acta Psychiatr Scand 1971; 47(4):484-509
Amerikan Psikiyatri Birliği (1999) Mental Bozuklukların Tanısal ve Sayımsal El Kitabı, Gözden Geçirilmiş Dördüncü Baskı (DSM-IVTR) Amerikan Psikiyatri Birliği, Washington DC: Çeviri Editörü Köroğlu E, Hekimler Yayın Birliği:Ankara, 2000
Atmaca M, Kuloğlu M, Tezcan AE. Monosemptomatik Hipokondriak Psikoz: Risperidon Kullanılan Bir Olgu. Klinik Psikofarmokoloji Bülteni - Bulletin of Clinical Psychopharmacology 2001; 11(1): 41-5
Konuk N, Atik L, Atasoy N, Ugur MB. Frontotemporal hypoperfusion detected by 99mTc HMPAO SPECT in a patient with olfactory reference syndrome. Gen Hosp Psychiatry 2006; 28(2):174-7
Aksu EE, Aksu H, Tabo A, Saatçioğlu Ö. Olfaktör referans sendromu: Olgu sunumu Düşünen Adam Psikiyatri ve Nörolojik Bilimler Dergisi 2010; 23(2): 133-6
Sayar K, Aksu G. Olfaktör Referans Sendromu: Bir Olgu Sunumu. Klinik Psikofarmakoloji Bülteni - Bulletin of Clinical Psychopharmacology 2003; 13(4):183-7
Buckley PF. Efficacy of quetiapine for the treatment of schizophrenia: a combined analysis of three placebo-controlled trials. Cur Med Res Opin 2004;20(9): 1357-63
Young AH, McElroy SL, Bauer M, Philips N, Chang W, Olausson B, et al. A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I). J Clin Psychiatry 2010;71(2): 150-62
Yargic IL, Corapcioglu A, Kocabasoglu N, Erdogan A, Koroglu G, Yilmaz D. A prospective randomized single-blind, multicenter trial comparing the efficacy and safety of paroxetine with and without quetiapine therapy in depression associated with anxiety. Int J Psychiatry Clin Prac 2004;8(4): 205-11
Çetin M. Tedaviye dirençli depresyonlarda yeni antipsikotiklerin yeri. Klinik Psikofarmakoloji Bülteni - Bulletin of Clinical Psychopharmacology 2010;20(1): 15-25.